2001181
Last Update Posted: 2015-10-15
Recruiting has ended
All Genders accepted | 18 Years-60 Years |
69 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)
The study is being conducted to evaluate the efficacy, safety and tolerability of 2% tofacitinib ointment (20 mg/g) BID (twice daily) in subjects with mild to moderate atopic dermatitis compared to placebo (vehicle) BID for 4 weeks.
Eligibility
Relevant conditions:
Dermatitis, Atopic
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov